Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
37.3M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$4.38B
-
Value change
-
+$211M
-
Put/Call ratio
-
0.25
-
Number of buys
-
144
-
Number of sells
-
-107
-
Price
-
$117.50
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2017
293 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2017.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 269 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.3M shares
of 152M outstanding shares and own 24.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.56M shares), VANGUARD GROUP INC (3.04M shares), BROWN CAPITAL MANAGEMENT LLC (2.15M shares), Select Equity Group, L.P. (2.02M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.96M shares), Neuberger Berman Group LLC (1.84M shares), BAMCO INC /NY/ (1.5M shares), Mairs & Power INC (1.45M shares), JANUS HENDERSON GROUP PLC (1.19M shares), and STATE STREET CORP (995K shares).
This table shows the top 269 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.